Literature DB >> 10889839

Impact of ovarian hyperstimulation on the luteal phase.

N S Macklon1, B C Fauser.   

Abstract

The contemporary approach to ovarian stimulation in IVF treatment results in supraphysiological concentrations of progesterone and oestrogen in the luteal phase. These sex steroids act directly and indirectly to mature the endometrium, thus influencing its receptivity to implantation. The development of endometrial receptivity is a complex process that may be altered by inappropriate exposure to sex steroids. Alterations in the oestrogen to progesterone ratio, growth factor concentrations and cell adhesion molecule profiles may occur after ovarian stimulation, potentially affecting the receptivity of the endometrium. Recent clinical IVF studies have shown that implantation rates and corpus luteum function are influenced by oestrogen concentrations during the early luteal phase. Few comparative studies have been performed, but after ovarian stimulation there is a reduced implantation rate and a higher pregnancy loss rate before pregnancies can be detected clinically compared with natural cycle conceptions. Novel approaches to ovarian stimulation aimed at achieving a more physiological luteal phase endocrinology are now being developed. Data from a recent pilot study by our laboratory, involving minimal ovarian hyperstimulation and no luteal phase support, are discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10889839

Source DB:  PubMed          Journal:  J Reprod Fertil Suppl        ISSN: 0449-3087


  15 in total

1.  Endometrial Receptivity and its Predictive Value for IVF/ICSI-Outcome.

Authors:  A Heger; M Sator; D Pietrowski
Journal:  Geburtshilfe Frauenheilkd       Date:  2012-08       Impact factor: 2.915

2.  Addition of gonadotropin releasing hormone agonist for luteal phase support in in-vitro fertilization: an analysis of 2739 cycles.

Authors:  Erhan Şimşek; Esra Bulgan Kılıçdağ; Pınar Çağlar Aytaç; Gonca Çoban; Seda Yüksel Şimşek; Tayfun Çok; Bülent Haydardedeoğlu
Journal:  J Turk Ger Gynecol Assoc       Date:  2015-06-01

3.  Effects of gonadotrophin releasing hormone analogues on human endometrial stromal cells and embryo invasion in vitro.

Authors:  Petra A B Klemmt; Fang Liu; Janet G Carver; Celine Jones; Dorothea Brosi; Jonathan Adamson; Helen J Mardon; Enda McVeigh
Journal:  Hum Reprod       Date:  2009-06-11       Impact factor: 6.918

4.  Serum estradiol/progesterone ratio on day of embryo transfer may predict reproductive outcome following controlled ovarian hyperstimulation and in vitro fertilization.

Authors:  Irmhild Gruber; Alexander Just; Monika Birner; Alexander Lösch
Journal:  J Exp Clin Assist Reprod       Date:  2007-03-19

5.  Contribution to More Patient-Friendly ART Treatment: Efficacy of Continuous Low-Dose GnRH Agonist as the Only Luteal Support-Results of a Prospective, Randomized, Comparative Study.

Authors:  Céline Pirard; Ernest Loumaye; Pascale Laurent; Christine Wyns
Journal:  Int J Endocrinol       Date:  2015-04-05       Impact factor: 3.257

6.  Effect of sildenafil citrate on endometrial preparation and outcome of frozen-thawed embryo transfer cycles: a randomized clinical trial.

Authors:  Razieh Dehghani Firouzabadi; Robab Davar; Farzaneh Hojjat; Mohamad Mahdavi
Journal:  Iran J Reprod Med       Date:  2013-02

7.  Assessment of the luteal phase in stimulated and substituted cycles.

Authors:  H M Fatemi
Journal:  Facts Views Vis Obgyn       Date:  2009

Review 8.  Fertility with early reduction of ovarian reserve: the last straw that breaks the Camel's back.

Authors:  Sabahat Rasool; Duru Shah
Journal:  Fertil Res Pract       Date:  2017-10-11

9.  Evaluation of the impact of gonadotropin-releasing hormone agonist as an adjuvant in luteal-phase support on IVF outcome.

Authors:  Dattaprasad B Inamdar; Abha Majumdar
Journal:  J Hum Reprod Sci       Date:  2012-09

10.  Human chorionic gonadotropin administration is associated with high pregnancy rates during ovarian stimulation and timed intercourse or intrauterine insemination.

Authors:  Mohamed F Mitwally; Sonya Abdel-Razeq; Robert F Casper
Journal:  Reprod Biol Endocrinol       Date:  2004-07-07       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.